In a move that could revolutionize how acne is treated, Sanofi has launched early-stage clinical trials for an investigational mRNA acne vaccine, a first-of-its-kind approach that leverages the same technology used in COVID-19 vaccines.
Acoziborole Winthrop, developed by DNDi and Sanofi, receives European Medicines Agency positive opinion as three-tablet, single-dose treatment for most common form of sleeping sickness - EurekAlert!
